Dartmouth Events

Medicine Grand Rounds: “Cellular Mechanism of Insulin Resistance: Implications for Obesity, Type 2 Diabetes and the Metabolic Syndrome”

Gerald I. Shulman, MD, PhD, FACP, MACE
 George R. Cowgill Professor of Medicine, Endocrinology Professor of Cellular and Molecular Physiology
 Investigator, Howard Hughes Medical Institute
 Co-Director, Yale Diabetes Research Center
 Director, Yale Mouse Metabolic Phenotyping Center

Friday, October 21, 2016
8:00am – 9:00am
DHMC- Auditorium E
Intended Audience(s): Public
Categories: Conferences

Co-Sponsored by the Section of Endocrinology and the Department of Medicine
The Geisel School of Medicine at Dartmouth

Objectives – Participants will be able to:

1. To understand the role of ectopic lipid in the pathogenesis of type 2 diabetes and the metabolic      syndrome.
2. To understand the molecular mechanisms of lipid-induced liver and muscle insulin resistance.
3. To understand the role of muscle insulin resistance in the pathogenesis of non-alcoholic fatty liver disease and dyslipidemia.

Dr. Shulman is an Investigator of the Howard Hughes Medical Institute and the George R. Cowgill Professor of Physiological Chemistry, Medicine and Cellular and Molecular Physiology at Yale University. He is also the Co-Director of the Yale Diabetes Research Center. Dr. Shulman completed his undergraduate studies in biophysics at the University of Michigan, and received his MD and PhD degrees from Wayne State University. Following an internship and residency at Duke University Medical Center, he did an endocrinology fellowship and the Massachusetts General Hospital-Harvard Medical School. Dr. Shulman completed additional postdoctoral work in molecular biophysics and biochemistry at Yale before joining the faculty at Harvard Medical School. He was subsequently recruited back to Yale, where he remains presently. Dr. Shulman has pioneered the use of magnetic resonance spectroscopy to non-invasively examine intracellular glucose and fat metabolism in humans that have led to several paradigm shifts in our understanding of type 2 diabetes. Dr. Shulman is a Fellow of the American Association for the Advancement of Science and he has been elected to the American Society for Clinical Investigation, the Association of American Physicians, The Institute of Medicine and the National Academy of Sciences. 

Dr. Shulman reported no conflicts of interest.

Please join the Department of Medicine in welcoming Dr. Gerald Shulman to Medicine Grand Rounds.

If you are unable to attend and would like to either view Grand Rounds live on your computer or if you would like to view it another time, please use this link. 

** The Dartmouth-Hitchcock Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education programs for physicians.**

** The Dartmouth-Hitchcock Medical Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. **

For more information, contact:
Jessica Kinzie

Events are free and open to the public unless otherwise noted.